A Randomized Phase II Trial of Captem or Folfiri As Second-Line Therapy in Neuroendocrine Carcinomas
EUROPEAN JOURNAL OF CANCER(2024)
关键词
Neuroendocrine carcinomas (NECs),Phase II trial,Folfiri,Captem,Circulating miRNA
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要